InVivo Therapeutics Corp Beta
Qual é o Beta de InVivo Therapeutics Corp?
O Beta de InVivo Therapeutics Holdings Corp é 1.07
Qual é a definição de Beta?
BETA indica se uma ação é mais ou menos volátil do que o mercado como um todo. Um beta menor que 1 indica que o estoque é menos volátil do que o mercado, enquanto um beta maior que 1 indica que o estoque é mais volátil. A volatilidade é medida como a flutuação do preço em torno da média.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de empresas na Setor Health Care em NASDAQ em comparação com InVivo Therapeutics Corp
O que InVivo Therapeutics Corp faz?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Empresas com beta semelhantes a InVivo Therapeutics Corp
- Nitto Denko tem Beta de 1.07
- Minerals Technologies tem Beta de 1.07
- Asia Orient tem Beta de 1.07
- China Aerospace International tem Beta de 1.07
- Umang Dairies tem Beta de 1.07
- Umicore tem Beta de 1.07
- InVivo Therapeutics Corp tem Beta de 1.07
- Playgon Games tem Beta de 1.07
- First Merchants tem Beta de 1.07
- Audinate tem Beta de 1.07
- Funtastic tem Beta de 1.07
- Canasil Resources tem Beta de 1.07
- Wuxi Biologics (Cayman) tem Beta de 1.07